Comparative Efficacy and Safety of Radial and Femoral Access for Percutaneous Coronary Intervention (PCI) in the Context of Novel Antithrombotic Regimens and Device Innovations: A 2022 Update
Full Text:
Abstract
Percutaneous coronary intervention (PCI) has emerged as a cornerstone therapy for coronary artery disease (CAD), the leading cause of morbidity and mortality worldwide. This study explores the comparative outcomes of radial and femoral access in PCI, particularly within high-risk patient subgroups, utilizing advanced antithrombotic therapies and radial-specific devices. Radial access demonstrated significant reductions in bleeding and vascular complications, especially among elderly patients, women, and those with acute coronary syndromes (ACS). Predictive models, incorporating patient-specific risk factors, highlighted the synergistic benefits of radial access combined with novel anticoagulants and specialized devices. Despite a modest increase in fluoroscopy time, radial access was associated with shorter hospital stays and enhanced procedural safety. These findings underscore the importance of adopting radial access as a preferred PCI approach, paving the way for personalized interventions and advancing clinical guidelines to optimize outcomes across diverse populations.JRCD 2022; 4(6): 127–132
Keywords
radial access, femoral access, coronary artery disease, antithrombotic therapy, vascular complications
References
Vis MM, Beijk MA, Grundeken MJ, Baan J, Koch KT, Wykrzykowska JJ, Arkenbout EK, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP. A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction. JACC: Cardiovascular Interventions. 2013 Apr;6(4):317-24.
Sanborn TA, Ebrahimi R, Manoukian SV, McLaurin BT, Cox DA, Feit F, Hamon M, Mehran R, Stone GW. Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Circulation: Cardiovascular Interventions. 2010 Feb;3(1):57-62.
Kumbhani DJ, Cannon CP, Beavers CJ, Bhatt DL, Cuker A, Gluckman TJ, Marine JE, Mehran R, Messe SR, Patel NS, Peterson BE. 2020 ACC expert consensus decision pathway for anticoagulant and antiplatelet therapy in patients with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention or with atherosclerotic cardiovascular disease: a report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2021 Feb 9;77(5):629-58.
Seto AH, Abu-Fadel MS, Sparling JM, Zacharias SJ, Daly TS, Harrison AT, Suh WM, Vera JA, Aston CE, Winters RJ, Patel PM. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC: Cardiovascular Interventions. 2010 Jul;3(7):751-8.
Sultan A, Lüker J, Andresen D, Kuck KH, Hoffmann E, Brachmann J, Hochadel M, Willems S, Eckardt L, Lewalter T, Senges J. Predictors of atrial fibrillation recurrence after catheter ablation: data from the German Ablation Registry. Scientific reports. 2017 Nov 30;7(1):16678.
Farhan S, Baber U, Mehran R. Bleeding Associated with Angiography and Percutaneous Coronary Intervention. The Interventional Cardiology Training Manual. 2018:503-22.
Franchi F, Rollini F, Rivas A, Wali M, Briceno M, Agarwal M, Shaikh Z, Nawaz A, Silva G, Been L, Smairat R. Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the CANTIC Study. Circulation. 2019 Apr 2;139(14):1661-70.
Lim HS, Farouque O, Andrianopoulos N, Yan BP, Lim CC, Brennan AL, Reid CM, Freeman M, Charter K, Black A, New G. Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock. JACC: Cardiovascular Interventions. 2009 Feb;2(2):146-52.
Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. Cardiovascular Interventions. 2015 Aug 24;8(10):1382-92.
Zhang ZQ, Yang YX, Li JA, Zeng RC, Guan SK. Advances in coatings on magnesium alloys for cardiovascular stents–a review. Bioactive materials. 2021 Dec 1;6(12):4729-57.
Refbacks
- There are currently no refbacks.
